ArticleCancer research2025

De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma.

Manon Teisseire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.